 |
 |
 |
|---|
AAB/NILA/CRB CORONAVIRUS Resource & News Center
Regulatory Resources
CDC
FDA
- FAQs on Testing for SARS-CoV-2
- Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2
- FDA Update - Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
- COVID-19 Educational Resources
- In Vitro Diagnostics EUAs
- Frequently Asked Questions (FAQ)
- Emergency Use Authorization
- Virtual Townhall Meetings
- Independent Evaluations of COVID-19 Serological Tests
Association Resources
AAB Webinar Recordings
- Part 1: COVID-19 Virology And Infections (Members Only)
- Part 2: COVID-19 Antibody Testing And Test Performance Data (Members Only)
- Part 3: COVID-19 Transmission Through The Environment And Tracking Down Cases Based On Wastewater Epidemiology (Members Only)
- Part 4: COVID-19 Host Immunogenetics And Innate Immunity (Members Only)
AAB/NILA/CRB Comments, Position Statements, Letters
6/13/2022 - FDA Authorizes First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages
